Fabrice Jardin, MD PhD^1*, Vibha Raghavan, MSc^2*, Samuel Tracy, PhD^3*, Sandhya Balasubramanian, MS^4*, Laurie H. Sehn, MD, MPH⁵, Christopher R. Flowers, MD, MS⁶, Franck Morschhauser, phd⁷, Alex F. Herrera, MD⁸, Marek Trněný, MD⁹, Jeff P. Sharman, MD¹⁰, Gilles Salles, MD, PhD¹¹, Hervé Tilly, MD, PhD¹, Jonathan W. Friedberg, MD, MMSc¹², Will Harris, MS^3*, Jamie H. Hirata, PharmD^13*, Calvin Lee, MD³, Yanwen Jiang, PhD^3* and Georg Lenz¹⁴

¹Centre Henri-Becquerel and University of Rouen, Rouen, France
²Hoffmann-La Roche Ltd, Mississauga, ON, Canada
³Genentech, Inc., South San Francisco, CA
⁴Genentech Inc., South San Francisco, CA
⁵BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada
⁶Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷University of Lille, Lille, France
⁸City of Hope, Duarte, CA
⁹Charles University General Hospital, Prague, Czech Republic
¹⁰Willamette Valley Cancer Institute and Research Center, Eugene, OR
¹¹Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹²University of Rochester, Rochester, NY
¹³Genentech, South San Francisco, CA
¹⁴University of Münster, Munster, Germany

Alexis Claudel^1*, Anne Ségolène Cottereau, MD^2*, Emmanuel Bachy, MD, PhD^3*, Pierre Feugier^4*, Rene-Olivier Casasnovas, MD^5*, Corinne Haioun, MD, PhD⁶, Herve Tilly, MD⁷, Nicolas Daguindau^8*, Guillaume Cartron, MD, Ph-D^9*, Emmanuelle Nicolas Virelizier, MD^10*, Pauline Brice^11*, Benoit Tessoulin^12*, Christophe Fruchart^13*, Sylvie Glaisner^14*, Alain Jacques Delmer, MD^15*, Emmanuel Fleck^16*, Gian Matteo Pica, MD^17*, Hacene Zerazhi, MD^18*, Stephanie Guidez^19*, Morgane Cheminant^20*, Luc Xerri, MD, PhD^21*, Laetitia Vercellino, MD, PhD^22*, Loïc Chartier^23*, Lucie Gomes^24*, Pierre-Julien Viailly^24*, Marie-Helene Delfau, MD PhD^25* and Franck Morschhauser, MD PhD²⁶

¹Hemato-biology, Henri Mondor University Hospital, CRETEIL, France
²Nuclear Medicine Department, Hopital Cochin, Paris, France
³Lyon-Sud Hospital Center, Pierre-Bénite, France
⁴Henri Poincaré University, Vandoeuvre Les Nancy, FRA
⁵CHU DE DIJON - HÔPITAL F. MITTERRAND, Dijon, FRA
⁶Lymphoid Malignancies Department, Henri Mondor University Hospital, AP-HP, Créteil, France
⁷Centre Henri-Becquerel, Rouen, France
⁸Hematologie, Centre Hospitalier Annecy Genevois, Metz-Tessy, FRA
⁹Centre Hospitalier Universitaire de Montpellier, Montpellier, France
¹⁰Hematology Department, Centre Léon Bérard, Lyon, FRA
¹¹Hematology Department, Hopital Saint Louis, Paris, FRA
¹²Hematology Department, CHU Nantes, Nantes, France
¹³Hématologie, Centre hospitalier de Dunkerque, Dunkerque, FRA
¹⁴Hématologie - Centre René Huguenin, Institut Curie, ST CLOUD, FRA
¹⁵Hôpital Robert Debré CHU de Reims, Reims Cedex, -, FRA
¹⁶Centre Hospitalier de La Rochelle, LA ROCHELLE, FRA
¹⁷Hematology department, CH Chambery, Chambery, France
¹⁸Oncologie Médicale et Hématologie clinique, CH d'Avignon - Hôpital Henri Duffaut, Avignon, France
¹⁹Hematolgy department, University Hospital of Poitiers, Poitiers, France
²⁰Department of Hematology, Necker Hospital, APHP, Paris, France
²¹Pathology Department, Institut Paoli Calmettes, Marseille, FRA
²²Nuclear Medicine Department, Hopital Saint Louis, Paris, France
²³LYSARC, Pierre Bénite, France
²⁴INSERM U918, Centre Henri Becquerel, Rouen, France
²⁵Hemato-biology, Henri Mondor University Hospital, Créteil, France
²⁶Hematology Department, Centre Hospitalier Régional Universitaire de Lille, Lille, AL, France

Bence Bátai^1*, Ákos Nagy, MD^1*, Tibor Nagy, PhD^1,2*, Gábor Bedics, MD^1*, Bence Gálik, PhD^3*, Luca Varga, MSc^1*, Péter Attila Király, MD, PhD^4*, András Masszi, MD, PhD⁴, Gábor Mikala, MD, PhD^5*, Péter Farkas, MD^6*, Tamás Masszi, MD, PhD^6*, Judit Demeter, MD, PhD^7*, Ádám Jóna, MD, PhD^8*, Piroska Pettendi, MD^9*, Attila Gyenesei, PhD^3*, Erika Tóth, MD, PhD^10*, Botond Timár, MD, PhD^1*, Judit Csomor, MD^11*, András Matolcsy, MD, PhD^11*, Tamás Schneider, MD, PhD^4*, Donát Alpár, PhD^1* and Csaba Bödör, PhD^1*

¹HCEMM-SU Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary
²Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
³Szentágothai Research Centre, University of Pécs, Pécs, Hungary
⁴Department of Hematology and Lymphoma Care, National Institute of Oncology, Budapest, Hungary
⁵South-Pest Central Hospital, National Institute for Hematology and Infectious Diseases, Budapest, Hungary
⁶Department of Internal Medicine and Hematology, Semmelweis University, Budapest, Hungary
⁷Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary
⁸Department of Internal Medicine, University of Debrecen, Debrecen, Hungary
⁹Department of Internal Medicine, Jász-Nagykun-Szolnok County Hetényi Géza Hospital, Szolnok, Hungary
¹⁰Department of Surgical and Molecular Pathology, National Institute of Oncology, Budapest, Hungary
¹¹Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary

Tomohiro Aoki, MD, PhD^1,2, Gerben Duns, PhD^3*, Shinya Rai, MD, PhD^3*, Andrew Lytle, MD, PhD³, Yifan Yin^3*, Clementine Sarkozy^4*, Stacy Hung, PhD^3*, Katy Milne^5*, Adele Telenius, MPhil, BSc^6*, Luke O`Brien^7*, Celia Strong^8*, Talia Goodyear^8*, Shaocheng Wu^2*, Katsuyoshi Takata, MD, PhD^9*, Tomoko Miyata-Takata^2*, Merrill Boyle, BSc^10*, Susana Ben-Neriah^2*, Andrew P. Weng, MD^2*, Andrew Roth, PhD^2*, Anca Prica, MD, MSc^11*, Robert Kridel¹¹, Brad Nelson^12*, Pedro Farinha, MD, PhD³, Kerry J. Savage, MD, MSc, BSc¹³, David W. Scott, MBChB, PhD³ and Christian Steidl, MD, PhD⁶

¹Princess Margaret Cancer Centre, Toronto, ON, Canada
²BC Cancer, Vancouver, Canada
³BC Cancer, Vancouver, BC, Canada
⁴Hematology departement, institut Curie, Paris, France
⁵Deeley Research Centre, BC Cancer, Victoria, BC, CAN
⁶Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
⁷BC Cancer, Centre for Lymphoid Cancer, Vancouver, BC, Canada
⁸Deeley Research Centre, BC Cancer, Victoria, Canada
⁹Division of Molecular and Cellular Pathology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan
¹⁰Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada
¹¹Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, Canada
¹²University of Victoria, Victoria, Canada
¹³Division of Medical Oncology, BC Cancer, Vancouver, BC, Canada

Julia Paczkowska, PhD^1*, Ming Tang, PhD^2,3*, Kyle T. Wright, MD, PhD^1,4,5*, Li Song, PhD^2,6*, Kelsey Luu, MBI^2,7*, Vignesh Shanmugam, MD^5,8, Emma L. Welsh, BE^5,9*, Jason L. Weirather, PhD^2*, Kathleen Pfaff, PhD^5,9*, Robert A. Redd, MS^2*, Zumla Cader, MBChB, PhD^1,10*, Elisa Mandato, PhD^1*, Jing Ouyang, PhD^1,11*, Gali Bai, MS^2,12*, Lee N. Lawton, PhD^1*, Philippe Armand, MD, PhD¹, Scott Rodig, MD, PhD^5,9, Xiaole Shirley Liu, PhD^2,13,14* and Margaret A. Shipp, MD¹

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
²Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
³Immunitas Therapeutics, Waltham, MA
⁴Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK
⁵Department of Pathology, Brigham and Women's Hospital, Boston, MA
⁶Department of Biomedical Data Science, Dartmouth College, Hanover, NH
⁷PathAI, Boston, MA
⁸Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA
⁹Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA
¹⁰Hematology, Oncology R&D, AstraZeneca, Cambridge, United Kingdom
¹¹Mechanism of Cancer Resistance Thematic Center, Bristol Myers Squibb, Cambridge, MA
¹²Department of Biomolecular Engineering in the Baskin School of Engineering, University of California Santa Cruz, Santa Cruz, CA
¹³Harvard T.H. Chan School of Public Health, Boston, MA
¹⁴GV20 Therapeutics, LLC, Cambridge, MA

Kyoko Yamaguchi, BSc^1*, Salma Abdelbaky^2*, Evgeny Arons, PhD^3*, Matthew Cross, MBBS, BSc^4*, Yue-Zhong Wu^5*, Christoph Weigel, PhD¹, Mirela Iulia Anghelina, MD, MPH^6*, Helen Parker^7*, Artur Kibler^8*, Marta Salido, PhD^9*, Constance Regina Baer, PhD¹⁰, Manja Meggendorfer, PhD¹⁰, Benjamin Durham, MD, PhD^11*, Omar Abdel-Wahab, MD¹¹, Seema A Bhat, MD², Gerard Lozanski, MD^12*, Kerry A Rogers, MD², Yonghong Wang^13*, Paul S. Meltzer, MD, PhD^14*, Sunil Iyengar, MBBS, PhD, MRCP¹⁵, Sascha Dietrich, MD^16*, Thorsten Zenz¹⁷, James S. Blachly¹⁸, Aurelie Verney^19*, Lucile Baseggio^20*, Alexandra Traverse-Glehen, MD, PhD^21*, Marc Seifert^22*, Ralf Kuppers, PhD^23*, Richard Burack, MD, PhD²⁴, Clive S Zent, MD²⁵, Versha Banerji, MD^26,27, James B. Johnston, MB²⁸, David Graham Oscier, MD, PhD²⁹, Renata Walewska, MD, PhD^30*, Kostas Stamatopoulos³¹, Torsten Haferlach, MD, PhD¹⁰, Ana Ferrer, MD, PhD^32*, Catherine Thieblemont, MD^33,34*, Francesco Forconi, MD, PhD, DM, FRCPath^7*, Robert J. Kreitman, MD³⁵, Michael R. Grever, MD², Jonathan C. Strefford, BSc³⁶, Piers Blombery, MBBS³⁷ and Christopher C. Oakes, PhD³⁸

¹Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
²Division of Hematology, The Ohio State University, Columbus, OH
³Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD
⁴Royal Marsden Hospital, Sutton, ENG, GBR
⁵The Ohio State University, Columbus, OH
⁶The Ohio State University, Columbus
⁷School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom
⁸Institute of Cellbiology, Essen, DEU
⁹Laboratori de Citogenètica, Servei de Patologia, Hospital del Mar, GRETNHE, IMIM, Barcelona, Spain
¹⁰MLL Munich Leukemia Laboratory, Munich, Germany
¹¹Memorial Sloan Kettering Cancer Center, New York, NY
¹²Department of Pathology, The Ohio State University, Columbus, OH
¹³National Institute of Health, Bethesda, MD
¹⁴NCHGR, NIH, Bethesda, MD
¹⁵Royal Marsden Hospital, London, GBR
¹⁶Heidelberg University Hospital, Heidelberg, DEU
¹⁷University of Zurich (UZH), Zurich, Switzerland
¹⁸Department of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH
¹⁹UCBL, Oullins Cedex, FRA
²⁰Department of Hematologic Laboratory, Hospices Civils De Lyon/GHS, Pierre Benite, FRA
²¹Department of Pathology, Lyon Sud Hospital, Pierre Benite, France
²²Institute For Cellbiology, Essen, DEU
²³University of Duisburg-Essen, Essen, DEU
²⁴Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY
²⁵Wilmot Cancer Institute, Department of Medicine, University of Rochester Medical Center, Rochester, NY
²⁶Paul Albrechtsen Research Institute, Univeristy of Manitoba and CancerCare Manitoba, Winnipeg, MB, Canada
²⁷Departments of Internal Medicine, Biochemistry & Medical Genetics, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba and CancerCare Manitoba, Winnepeg, Canada
²⁸Cancer Care Manitoba, Winnipeg, MB, CAN
²⁹Division of Haematology, University Hospitals Dorset, Bournemouth, United Kingdom
³⁰Molecular Pathology, University Hospitals Dorset, Bournemouth, United Kingdom
³¹Institute of Applied Biosciences, Centre for Research and Technology Hellas, Asvestohori, Greece
³²Laboratori de Citologia Hematològica, Servei de Patologia, Hospital del Mar, GRETNHE, IMIM, Barcelona, Spain
³³Assistance Publique & Hôpitaux de Paris (APHP), Hôpital Saint-Louis, Hémato-oncologie, Université de Paris, Paris, France
³⁴Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Hemato-oncologie, Université de Paris, Paris, France
³⁵National Institutes of Health, Bethesda, MD
³⁶School of Cancer Sciences, Faculty of Medicine, Univ. of Southampton, Southampton, United Kingdom
³⁷Peter Maccallum Cancer Centre, East Melbourne, VIC, Australia
³⁸Division of Hematology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, OH